Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Average Length of Rental for Repairable Vehicles: Q4 2020
The quarterly LOR summary is produced by
Mitchell
Article
COVID—A Year Later
How the World (May Be) Forever Changed by COVID-19 One year ago this week, our Company sent out the first set of employee notices to adop
Auto Casualty
Article
Drug of the Month: Insights Into COVID-19 Vaccines and Workers' Comp
COVID-19 vaccination efforts continue to progress, after the
Mitchell
Article
Current Used Vehicle Market Conditions: Q4 2020
December 2020 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Chief Economist, KAR Global.
Mitchell
News Release
Mitchell Introduces New Alternative for AI-Enabled Claims Processing Through Collaboration with Claim Genius
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
Article
WorkCompWire: Case Managers Help Alleviate Covid-19’s Head-on Collision with the Opioid Epidemic
As 2020 began, a persistent opioid overdose epidemic was near the forefront of a list of national concerns in the United States.